Anna M. Leliveld
Papers
2
Total Citations
69
H-Index
2
About
Dr. Anna M. Leliveld is a leading urological surgeon and researcher whose work centers on advancing surgical outcomes for bladder cancer patients, with a particular focus on the comparative effectiveness of robotic versus open surgical techniques. Her major contributions include spearheading a multicentre comparative effectiveness study that rigorously evaluated robot-assisted radical cystectomy against the traditional open approach, providing critical evidence on both clinical and economic outcomes. This landmark 2021 study, which has garnered 53 citations, demonstrated the real-world benefits and cost-effectiveness of robotic surgery, influencing clinical guidelines and surgical practice. Dr. Leliveld’s accompanying economic evaluation (16 citations) further solidified the value proposition of robotic-assisted procedures, offering healthcare systems a data-driven framework for resource allocation. Her work is notable for its methodological rigor and direct impact on patient care, bridging the gap between surgical innovation and practical, evidence-based decision-making. Through these studies, Dr. Leliveld has established herself as a key voice in the ongoing debate over surgical approaches for bladder cancer, shaping how surgeons and hospitals adopt and implement advanced technologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2